Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICC APL Study 01 for Childhood Acute Promyelocytic Leukemia
NCT01226303Phase 3Unknown
- Sponsor
- Italian Association of Pediatric Hematology and Oncology
- Start
- Jan 2009
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin in acute promyelocytic leukemia (APL), sponsored by Italian Association of Pediatric Hematology and Oncology. Status: unknown.
02
Drugs
tretinoin
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT01226303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226303.